Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
formerly GVAX Melanoma vaccine
Also known as: BioSante melanoma vaccine
print preview
bookmark
share with colleague
General Information
Company
BioSante Pharmaceuticals Inc.
Description
Allogeneic cancer vaccine engineered to secrete granulocyte macrophage colony-stimulating factor (GM-CSF)
Molecular Target
Mechanism of Action
Vaccine
Latest Stage of Development
Phase I
Indication
Melanoma
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy